ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1410	National Cancer Institute	Html	en	Endometrial Cancer Prevention (PDQ®)–Health Professional Version	Expert-reviewed information summary about factors that may influence the risk of developing endometrial cancer and about research aimed at the prevention of this disease.	Surgical Adjuvant Breast 0.47836 Obstet Gynecol 0.483376 World Cancer Research 0.452806 endometrial carcinoma 0.52954 Engl J Med 0.456388 American Cancer Society 0.497798 Br J Cancer 0.455416 case-control study 0.441437 Int J Cancer 0.478131 early-stage breast cancer 0.461817 intentional weight loss 0.529248 breast cancer treatment 0.473891 breast cancer patients 0.472714 body mass index 0.470175 endometrial cases 0.529694 Cancer Causes Control 0.452081 Natl Cancer Inst 0.529481 lower endometrial cancer 0.563354 postmenopausal endometrial cancer 0.554715 modifiable risk factor 0.44186 endometrial cancer 0.948645 invasive breast cancer 0.472622 Cancer Treat Rep 0.454232 et al. 0.498732	early breast cancer 0.472532 tamoxifen-treated breast cancer 0.462067 nonpolyposis colorectal cancer 0.457467 endometrial cancer cases 0.601622 polycystic ovarian syndrome 0.445837 Cancer Epidemiol Biomarkers 0.47249 endometrial cancer risk 0.82277 Cancer Facts 0.44862 PUBMED Abstract 0.515106 Nutr Cancer 0.444116 widespread endometrial cancer 0.555715 Epidemiol Biomarkers Prev 0.442397 endometrial cancer incidence 0.612962 Breast Cancer Prevention 0.475561 African American women 0.440785 invasive gynecologic cancer 0.464853 postmenopausal women 0.497969 Abstract 0.52778 breast cancer 0.526041 adjuvant tamoxifen 0.441172 physical activity 0.445711 Breast Cancer Study 0.467445 breast cancer incidence 0.479289 National Surgical Adjuvant 0.475167	CLICK HERE
1501	National Cancer Institute	Html	en	Childhood Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood Hodgkin lymphoma.	nodular sclerosis hodgkin 0.365708 refractory pediatric Hodgkin 0.351319 refractory Hodgkin 0.416042 early Hodgkin lymphoma 0.394054 Hodgkin lymphoma cases 0.403293 Hodgkin disease-added value 0.362383 early-stage hodgkin lymphoma 0.391985 lymphocyte-predominant hodgkin 0.393688 Radiat Oncol Biol 0.45608 risk Hodgkin lymphoma 0.399452 favorable-risk Hodgkin lymphoma 0.388818 Hodgkin lymphoma histology 0.402552 pediatric hodgkin lymphoma 0.479624 German-Austrian Pediatric Hodgkin 0.419443 classic Hodgkin lymphoma 0.417403 pediatric Hodgkin disease 0.379402 high-risk Hodgkin lymphoma 0.432447 Hodgkin Study Group 0.371284 sclerosis Hodgkin lymphoma 0.410888 newly diagnosed Hodgkin 0.350548 Hodgkin lymphoma treatment 0.38529 childhood hodgkin lymphoma 0.384013 familial classical Hodgkin 0.365775 lymphocyte-predominant Hodgkin lymphoma-experience 0.349402 childhood hodgkin 0.486255	cancer survivor study 0.348591 et al. 0.539517 lymphocyte-rich classical Hodgkin 0.347809 pediatric hodgkin 0.578037 intermediate-risk hodgkin lymphoma 0.423631 advanced Hodgkin lymphoma 0.416897 refractory Hodgkin lymphoma 0.395506 PUBMED Abstract 0.412711 unfavorable pediatric Hodgkin 0.351719 Hodgkin lymphoma subtype 0.402744 Lymphocyte-predominant Hodgkin lymphoma 0.388987 advanced-stage Hodgkin 0.357413 lymphocyte predominant Hodgkin 0.374597 Abstract 0.561102 Clin Oncol 0.905331 Hodgkin Lymphoma Group 0.412086 classical Hodgkin lymphoma 0.427321 Oncol Biol Phys 0.463188 Hodgkin disease 0.410937 childhood cancer survivor 0.348315 unfavorable childhood Hodgkin 0.356068 hodgkin lymphoma 0.82441 recurrent Hodgkin lymphoma 0.392381 predominant Hodgkin lymphoma 0.394303	CLICK HERE
1513	National Cancer Institute	Html	en	Pancreatic Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of pancreatic cancer.	pancreatic carcinoma E6201 0.398831 unresectable pancreatic carcinoma 0.359985 pancreatic malignancy 0.311753 Engl J Med 0.337007 Ann Surg 0.317423 German CONKO-study group 0.318318 phase iii trial 0.413157 pancreatic tumors 0.328586 der Schelling GP 0.325496 randomized phase 0.350612 advanced pancreatic adenocarcinoma 0.470438 randomized trial 0.376847 patients 0.470655 investigational new drug 0.321651 Cooperative Oncology Group 0.454021 van der Schelling 0.325555 Moore MJ 0.343635 fixed-dose rate infusion 0.313379 pancreatic carcinoma 0.542646 Ann Oncol 0.304631 et al. 0.690156 Best supportive care 0.315629 study 0.356854 Expandable metal stents 0.329142	phase ii trial 0.320548 Hammel et al. 0.336299 Oncology Group study 0.328761 Clinical Trials Group 0.319844 gemcitabine-based induction chemotherapy 0.328647 National Cancer Institute 0.337583 den Bosch RP 0.325608 advanced unresectable pancreatic 0.366836 metastatic pancreatic cancer 0.353118 advanced pancreatic cancer 0.926655 advanced pancreatic carcinoma 0.404683 unresectable periampullary adenocarcinoma 0.332936 first-line therapy 0.306838 van den Bosch 0.324595 refractory pancreatic cancer 0.407704 advanced pancreas cancer 0.35576 Abstract 0.559395 Clin Oncol 0.91428 unresectable pancreatic cancer 0.410252 Canada Clinical Trials 0.318756 Eastern Cooperative Oncology 0.46104 drug treatment program 0.320206 gemcitabine 0.380059 active chemotherapy regimens 0.332336	CLICK HERE
1623	National Cancer Institute	Html	null	Gonzalez Regimen (PDQ®)–Health Professional Version	The Gonzalez regimen is a specialized diet that uses enzymes, supplements, and other factors in cancer management based on a theory that involves the use of pancreatic enzymes to help the body get rid of toxins that lead to cancer. Read about existing clinical data in this expert-reviewed summary.			CLICK HERE
1715	National Cancer Institute	Html	en	Tests to Detect Colorectal Cancer and Polyps	A fact sheet that discusses the advantages and disadvantages of several colorectal cancer screening tests.	standard colonoscopy 0.642704 average risk 0.571434 sigmoidoscopy screening 0.568313 entire colon 0.614214 colorectal polyps 0.605561 abnormal growths 0.57234 colon problems 0.570159 Occult Blood Test 0.556564 early-stage colorectal cancer 0.600935 occult blood tests 0.564372 thorough cleansing 0.581775 asymptomatic colorectal cancer 0.60263 flexible lighted tube 0.561607 colorectal cancer screening 0.734621 flexible sigmoidoscopy screening 0.562785 small polyps 0.567222 digital rectal examination 0.560544 polyps 0.617192 colorectal cancer 0.956004 test 0.736074 new colorectal cancer 0.625336 guaiac FOBT 0.612613 single-specimen guaiac fobt 0.570386 inflammatory bowel disease 0.568257 ) colonoscopy. 0.566733	colon cancer incidence 0.618181 acceptable screening tests 0.563922 fecal occult blood 0.636365 colorectal cancers 0.601521 rectum 0.592026 colon tissue 0.560628 lower colon 0.576523 colon cancer mortality 0.592993 United States 0.573668 Additional procedures 0.566333 colonoscopy screening methods 0.603294 False-positive test results 0.579985 stool sample 0.563739 colorectal cancer incidence 0.613064 colon cancer 0.621651 fecal immunochemical test 0.563508 stool dna test 0.61197 people 0.593294 virtual colonoscopy 0.697133 cancer screening tests 0.581698 family history 0.558032 sigmoid colon 0.589237 colon 0.791161 et al 0.626521	CLICK HERE
1777	National Cancer Institute	Html	es	El dolor y el cáncer (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del dolor como una complicación a causa del cáncer o su tratamiento. Se tratan abordajes para el control y el tratamiento del dolor relacionado con el cáncer.	Moderate Cancer Pain 0.337641 among patients with 0.313833 Curr Pain Headache 0.353041 Palliat Nurs 0.30942 Chronic Pain Syndromes 0.356907 Breakthrough Pain Study 0.329475 Pain Questionnaire 0.327384 Jensen MP 0.310829 Cancer Therapy 0.30947 with breast cancer 0.313155 Edmonton Symptom Assessment 0.309493 Pain Terms 0.351866 pain management 0.434176 Natl Cancer Inst 0.310759 Hui D 0.310443 pain syndromes 0.398674 Faces Pain Scale 0.329845 Pain Res 0.344114 patients with 0.479951 Pain Symptom Manage 0.524062 Pain Experience among 0.326556 Pain Management Nursing 0.328639 chronic pain 0.526592 dolor).¿El dolor 0.346176 Oncol Nurs Forum 0.309327	peor dolor 0.357775 pain assessment 0.342098 Care Cancer 0.331083 breakthrough pain 0.366572 palliative care 0.309739 Hosp Palliat Care 0.329839 Faces Pain 0.365306 Pain related 0.328906 pain assessment toolkit 0.327388 pain control 0.351552 patients with depression 0.30909 Brief Pain Inventory 0.377512 Pain Headache Rep 0.352431 cancer pain 0.974628 cancer pain prognostic 0.363979 pain experience 0.342944 Clin Oncol 0.363176 Palliat Med 0.324432 pain's interference with 0.332203 breast cancer 0.321556 Bruera E 0.316817 edmonton staging system 0.310908 systematic review 0.31986 Faces Pain Scale-Revised 0.327413	CLICK HERE
1955	National Cancer Institute	Html	es	Tratamiento de la micosis fungoide (incluso el síndrome de Sézary) (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la micosis fungoide (incluso el síndrome de Sézary).	siguientes procedimientos 0.303227 células madre 0.320527 estadio iv 0.313697 La micosis fungoide 0.416261 llamada terapia 0.301315 Estadio IIA 0.301756 vía oral 0.300639 Estadio IIB 0.301746 rayos x 0.300779 estadio ivb 0.303346 estadio ib 0.303433 enlace drugs approved 0.306299 estadio ia 0.303396 radioterapia ultravioleta 0.303448 micosis fungoide 0.995318 célula madre mieloide 0.305243 células t 0.307128 madre sanguíneas maduras 0.302125 luz solar 0.300631 estadio iva 0.303278	quimioterapia sistémica 0.305438 National Cancer Institute 0.300622 Instituto Nacional 0.301086 célula madre linfoide 0.305924 PDQ Tratamiento 0.301318 partículas minúsculas 0.300672 presente sección 0.300525 llamada fotoquimioterapia 0.300664 Physician Data Query 0.302237 Non-Hodgkin Lymphoma 0.303589 estadio iii 0.306895 lesiones cutáneas 0.300795 radiación ultravioleta a 0.301198 célula madre 0.319745 luz ultravioleta 0.30088 ósea elabora células 0.304191 radiación ultravioleta 0.315951 Sézary recidivantes 0.302362 siguientes sumarios 0.301672 siguientes pruebas 0.301109	CLICK HERE
3670	National Cancer Institute	Html	es	Estudio TAILORx indica que mujeres con riesgo bajo de recurrencia de cáncer de seno pueden abstenerse de quimioterapia	Resumen de resultados del estudio TAILORx indica que mujeres con cáncer de seno receptor de hormonas en estadio inicial tienen un riesgo bajo de recurrencia según una prueba de expresión de 21 genes.	Assigning Individualized Options 0.731016 NIC-Clinical Trials Group 0.677172 Therapy Evaluation Program 0.674291 quimioterapia adyuvante mejora 0.979078 doctor joseph sparano 0.667749 doctora jo anne 0.660047 llamada puntuación 0.615517 Estados Unidos 0.857653 NRG Oncology 0.56481	excelentes resultados 0.548811 cuáles mujeres 0.873744 Oncotype DX® 0.57646 invasivo enfermedad 0.55814 New England Journal 0.693093 Clinical Oncology 0.572538 Nueva Zelanda 0.530968 estudio tailorx 0.733998	CLICK HERE
16838	National Cancer Institute	Html	en	University of Texas — Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology	The focus of the University of Texas MD Anderson Cancer Nanotechnology Training Center is presented here.	unique boot camp 0.665183 lab management skills 0.648892 Rice University 0.515834 M.D. 0.338543 Objectives 0.334693 MD Anderson 0.892403 preparation 0.332958 independent careers 0.500052 problem 0.335383 MD Anderson CNTC 0.66004 Ph.D. 0.338612 seminar experiences 0.507875 translational research 0.966631 academic labs 0.516268 hands-on coursework 0.547621 project management 0.489839 Konstantin Sokolov 0.587384 future leaders 0.517794 independent research project 0.702082 Texas 0.33468 cancer nanotechnology 0.891595 translational research projects 0.795763 training program 0.532137 multidisciplinary mentorship 0.538033 post-doctoral training 0.533942	trainees 0.545607 specific interests 0.517161 Rebecca 0.339233 research fellowship grant 0.692269 multidisciplinary field 0.50801 Ph.D 0.333304 cancer translational research 0.824834 Cancer Management 0.515303 gap 0.336671 Principal Investigator 0.540969 Didactic coursework 0.550767 completion 0.335106 Center 0.334629 MD Anderson Cancer 0.714625 NCI Nanotechnology Characterization 0.789772 program faculty mentors 0.704052 current opportunities 0.49661 federal resources 0.494134 new discoveries 0.52212 Sunil Krishnan 0.581597 deep understanding 0.497785 barriers 0.38628 introductory course 0.486248 Training Focus 0.539936	CLICK HERE
17278	National Cancer Institute	Html	es	Preparación para cuidar a un enfermo con cancer	Cuidar a alguien con cáncer avanzado trae desafíos y preocupaciones nuevas. Las personas que cuidan a pacientes deben estar al tanto de muchas cosas y planificar el cuidado de su ser querido.	dándoles oportunidad 0.826428 !No hables así¡ 0.973126 Nueva York 0.867641 principales formas 0.895606 Oxford University 0.86575	Lynna J 0.87542 busque consejo 0.895137 mejores tratamientos 0.878203 surgen preguntas 0.922072	CLICK HERE